Qualitative Platelet Disorders Treatment Market Trends
Growth Drivers
- Growing Changes in Lifestyle – Changes in lifestyle and nutrition among people across the globe have led to a rise in the occurrence of illnesses including obesity, diabetes, and hypertension, which are risk factors for qualitative platelet disorders. As per data, over 600,000 fatalities in the United States occur as a result of unhealthy nutrition each year.
- Rising Geriatric Population – The elderly population is more prone to qualitative platelet abnormalities and the rising number of elderly populations across the globe is estimated to drive market growth. Lately, there are more than 40 million senior citizens in the United States who are 65 or older. It is predicted that this number is expected to rise by more than 80 million by 2050.
- Increasing Health Spending – To address qualitative platelet abnormalities, surgery may occasionally be required. Increasing healthcare spending improves access to competent doctors and specialized surgical facilities wich is further expected to contribute to the market growth. According to the most recent expenditure data, health spending in the US rose by over 9% in 2020.
- Surging Demand for Drugs – It is expected that consumption of several medications, including high-dose penicillin, as well as ethanol, can cause platelet dysfunction as a side effect, which in turn is anticipated to drive the market growth. It was discovered in the US the usage of medications prescribed by retail pharmacies increased by over 2% yearly.
Challenges
- Exorbitant Cost of Treatment - The high cost associated with the treatment of qualitative platelet disorders is one of the major factors predicted to slow down the market growth. For instance, the requirement for long-term care, regular monitoring, and the use of pricey drugs or procedures, treating qualitative platelet abnormalities can be expensive. In addition, in extreme situations of qualitative platelet abnormalities, platelet transfusions can be necessary. Depending on how severe the illness is, these transfusions may need to be repeated frequently and might increase the expenses.
- Insufficient Access to Appropriate Care in Middle- and Low-Income Countries
- Absence of Reimbursement Policies
Qualitative Platelet Disorders Treatment Market: Key Insights
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.9% |
|
Base Year Market Size (2024) |
USD 3.55 billion |
|
Forecast Year Market Size (2037) |
USD 10.75 billion |
|
Regional Scope |
|
